| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -26.24M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ANRO returned +779.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +92.6% |
| 1 year | +779.0% |
| All-time high | $34.28 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ANRO would be worth today ›No. Alto Neuroscience, Inc. has not paid a dividend in the past 12 months.
Alto Neuroscience, Inc. stock trades on NYSE under the ticker symbol ANRO.
Alto Neuroscience, Inc. is part of the Healthcare sector.
Alto Neuroscience, Inc. has a market cap of 1.35B USD, based on the latest quote.
Alto Neuroscience, Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
